HC Wainwright & Co. Maintains Buy on Alpha Tau Medical, Raises Price Target to $16

Benzinga · 2d ago
HC Wainwright & Co. analyst Yi Chen maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and raises the price target from $15 to $16.